Etrasimod Looks Safe for Ulcerative Colitis Out to 2.5 Years Etrasimod Looks Safe for Ulcerative Colitis Out to 2.5 Years
Experts recommend an electrocardiogram to screen for some heart-related risks before prescribing.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 12, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
Eyenovia's Mydcombi Gets FDA Nod for Pupil Dilation Eyenovia's Mydcombi Gets FDA Nod for Pupil Dilation
The new drug is to be used with Optejet dispenser technology.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 8, 2023 Category: Drugs & Pharmacology Tags: Ophthalmology News Alert Source Type: news
Colchicine's 2010 Price Spike Had Major Impact on Gout Care Colchicine's 2010 Price Spike Had Major Impact on Gout Care
Colchicine prescriptions dropped sharply and patient visits for gout-related symptoms increased significantly after a 2010 US Food and Drug Administration ruling that enabled a price spike.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 8, 2023 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
Olanzapine Effective for Higher-Risk Chemo-Induced Nausea Olanzapine Effective for Higher-Risk Chemo-Induced Nausea
The antipsychotic improves on standard antiemetic therapy in patients known to be more prone to nausea and vomiting with chemotherapy.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 8, 2023 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news
Wireless Neurostimulation Safe for Urge Incontinence Wireless Neurostimulation Safe for Urge Incontinence
More than 8 in 10 women who received the treatment showed improvement, a new study found.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 30, 2023 Category: Drugs & Pharmacology Tags: Urology News Source Type: news
FMT in a Pill: FDA OKs Second Product to Prevent Recurrent C difficile FMT in a Pill: FDA OKs Second Product to Prevent Recurrent C difficile
Clinicians now have two approved options for recurrent infections after antibiotic treatment.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 29, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
Perinatal HIV Nearly Eradicated in US Perinatal HIV Nearly Eradicated in US
Fewer women are giving birth to newborns with HIV, but the success does not extend to some communities.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 18, 2023 Category: Drugs & Pharmacology Tags: Pediatrics News Source Type: news
Pediatric Crohn's: Adalimumab+Methotrexate Offers Strong Benefit Pediatric Crohn's: Adalimumab+Methotrexate Offers Strong Benefit
A landmark trial suggests adding low-dose methotrexate should be strongly considered in children with Crohn ' s disease who are starting adalimumab.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 14, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
Abortion Wars Dangerous for Doctors, Pharma to Ignore? Abortion Wars Dangerous for Doctors, Pharma to Ignore?
The AMA ducked the abortion issue for years and now sees its members ' professional opinions second-guessed by lawmakers and judges. Pharma is following the same playbook.Kaiser Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 12, 2023 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Source Type: news
Study: Prenatal Supplements Fail to Meet Nutrient Needs Study: Prenatal Supplements Fail to Meet Nutrient Needs
Researchers found most prenatal vitamins fall short of bridging nutritional gaps for pregnant women.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 10, 2023 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Source Type: news
FDA Withdraws Approval of Makena FDA Withdraws Approval of Makena
The medication was approved in 2011 to reduce the risk for preterm birth, but a postmarketing study did not show clinical benefit.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 6, 2023 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Alert Source Type: news
Mirvetuximab: Practice Changing for Some Ovarian Cancers Mirvetuximab: Practice Changing for Some Ovarian Cancers
Response rates were superior to those seen with other single agents in patients with platinum-resistant disease and tumors positive for folate receptor alpha.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 30, 2023 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news
Telehealth Services Tied to a Major Reduction in Overdose Deaths Telehealth Services Tied to a Major Reduction in Overdose Deaths
The rate of opioid overdose deaths during the pandemic was 33% lower among people who received OUD-related telehealth services and 59% lower among those who received OUD medication from a treatment center.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 29, 2023 Category: Drugs & Pharmacology Tags: Psychiatry News Source Type: news
Osteoporosis Drugs May Extend Life After Fracture Osteoporosis Drugs May Extend Life After Fracture
Large database study shows lower mortality within 5 years after a fracture among individuals using longer acting, antiresorptive osteoporosis medications, such as bisphosphonates.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 24, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
California Picks Generic Drug Company to Produce Low-Cost Insulin California Picks Generic Drug Company to Produce Low-Cost Insulin
Gov. Gavin Newsom, who blasted pharmaceutical companies for gouging Californians, is moving ahead with state-branded insulin. He ’s also eyeing other generic drugs.Kaiser Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 20, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
